Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 536238, 12 pages
Research Article

S-Nitrosoglutathione Reductase Plays Opposite Roles in SH-SY5Y Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis

1Cell Stress and Survival Unit, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark
2IRCCS Santa Lucia Foundation and Department of Biology, University of Rome “Tor Vergata”, 00133 Rome, Italy
3The Beatson Institute for Cancer Research, Cancer Research UK, Glasgow G61 1BD, UK
4Unit of Radiation Biology and Human Health, ENEA-Casaccia, 00123 Rome, Italy
5Institute for Translational Pharmacology, CNR, 00133 Rome, Italy

Received 26 December 2014; Revised 22 March 2015; Accepted 13 May 2015

Academic Editor: Jan G. C. van Amsterdam

Copyright © 2015 Salvatore Rizza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Salvatore Rizza, and Giuseppe Filomen, “Tumor suppressor roles of the denitrosylase GSNOR,” Critical Reviews in Oncogenesis, vol. 21, no. 5-6, pp. 433–445, 2016. View at Publisher · View at Google Scholar
  • Nannan Jia, Guoping Li, Pu Huang, Jiazhi Guo, Lugang Wei, Di Lu, and Shaochun Chen, “Protective role and related mechanism of Gnaq in neural cells damaged by oxidative stress,” Acta Biochimica et Biophysica Sinica, vol. 49, no. 5, pp. 428–434, 2017. View at Publisher · View at Google Scholar
  • Salvatore Rizza, and Giuseppe Filomeni, “Chronicles of a reductase: Biochemistry, genetics and physio-pathological role of GSNOR,” Free Radical Biology and Medicine, 2017. View at Publisher · View at Google Scholar
  • Scott D. Barnett, and Iain L. O. Buxton, “The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy,” Critical Reviews in Biochemistry and Molecular Biology, pp. 1–15, 2017. View at Publisher · View at Google Scholar
  • G. Nagesh Babu, and Manjeet Gupta, “Therapeutics in Neurodegenerative Disorders: Emerging Compounds of Interest,” Emerging Trends in Chemical Sciences, pp. 37–56, 2017. View at Publisher · View at Google Scholar
  • Claudia Consales, Claudia Cirotti, Giuseppe Filomeni, Martina Panatta, Alessio Butera, Caterina Merla, Vanni Lopresto, Rosanna Pinto, Carmela Marino, and Barbara Benassi, “Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Michela Campolo, Giovanna Casili, Flavia Biundo, Rosalia Crupi, Marika Cordaro, Salvatore Cuzzocrea, and Emanuela Esposito, “The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2,” Antioxidants & Redox Signaling, 2017. View at Publisher · View at Google Scholar
  • Cristiana Valle, and Maria Teresa Carrì, “Cysteine Modifications in the Pathogenesis of ALS,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at Publisher · View at Google Scholar
  • Oscar Arriagada, Adriana V. Treuer, and Daniel R. González, “Cardioprotective Effects of S-Nitrosothiols in Ischemia- Reperfusion: Role for Mitochondria and Calcium Channels,” Free Radicals, Antioxidants and Diseases, 2018. View at Publisher · View at Google Scholar
  • Salvatore Rizza, Paola Giglio, Fiorella Faienza, and Giuseppe Filomeni, “Therapeutic Aspects of Protein Denitrosylation,” Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders, pp. 173–189, 2019. View at Publisher · View at Google Scholar